Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

3.337 -0.413 (-11.00%)
Streaming Delayed Price Updated: 12:32 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
7 Growth Stocks With Huge Return Potential for Long-Term Investors
Overdone worries about a recession are poised to disappear, causing many excellent growth stocks to soar in the coming months. 
Via InvestorPlace
Why Shares of Bionano Genomics Are Up Monday
The life sciences company said it expects another improved quarter of revenue. 
Via The Motley Fool
7 Stocks That Could Skyrocket in the Next 12 Months
With the macro environment becoming excellent and much of the Street starting to turn bullish, it's time to find superb stocks to buy. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Moderna, Roblox, State Street And Other Big Stocks Moving Lower On Monday
U.S. stocks traded mixed, with the Dow Jones dropping over 25 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Earnings Preview: Bionano Genomics
Via Benzinga
Is Bionano Genomics Stock a Buy Now?
Revenue growth is likely on the way, but the stock price doesn't reflect that potential. 
Via The Motley Fool
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. 
Via Benzinga
Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket
Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday. 
Via Benzinga
3 Supercharged Growth Stocks With 662% to 741% Upside, According to Wall Street
These fast-paced stocks are on the cutting edge of innovation, and select Wall Street analysts and pundits expect them to skyrocket. 
Via The Motley Fool
The 3 Most Promising Penny Stocks to Buy in April
Here are three of the most promising penny stocks from some of the most popular growth sectors emerging in 2023 
Via InvestorPlace
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Buy This Magnificent Growth Stock Before It's Too Late
Bionano is gaining momentum and could soon be approaching escape velocity. 
Via The Motley Fool
Is Bionano Genomics a Risk Worth Taking at This Price?
Revenues are increasing, but with its meme stock heyday well in the rearview mirror, it's fair to ask whether Bionano Genomics stock is a risk worth taking 
Via MarketBeat
Stocks React To February Jobs Report: The Winners And Losers
The markets have offered investors a rollercoaster ride this week, with a flurry of activity and developments that have sent shockwaves through various sectors. 
Via Benzinga
Bionano Genomics (BNGO) Q4 2022 Earnings Call Transcript
BNGO earnings call for the period ending December 31, 2022. 
Via The Motley Fool
BioNano Genomics Reports Q4 Beat, Issues FY23 Guidance: What Investors Need To Know
BioNano Genomics Inc (NASDAQ: BNGO) shares are trading marginally lower during Thursday's after-hours session after the company reporte 
Via Benzinga
This Growth Stock Is Down 38% and Wall Street Says It's Worth Buying Hand Over Fist
With no recent stumbles and more growth on the way, buying shares now could be a smart move. 
Via The Motley Fool
7 Stocks to Buy on Weakness While You Can
The American economy is very strong, so investors should look for good stocks to buy on weakness at this point. 
Via InvestorPlace
Get Ready to Soar: 2 High-Octane Growth Stocks Wall Street Expects to Climb in 2023
Both have growth catalysts on the way, and plenty of recurring revenue too. 
Via The Motley Fool
Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled This Week
These cutting-edge biotech companies quickly fell out of favor with investors this week. 
Via The Motley Fool
3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street
Select analysts expect these small-caps stocks to catapult higher in the new year. 
Via The Motley Fool
NVIDIA Outlook Improving: Watchlist Candidate for 2023
With less than three weeks gone so far this year, we’re once again excited about NVIDIA’s stock, and aren’t the only ones. 
Via MarketBeat
Topics Economy
Exposures Supply Chain
Dear JAGX Stock Fans, Mark Your Calendars for Jan. 12
Fans of Jaguar Health (JAGX) stock will want to keep an eye on the company tomorrow as it prepares for an investor webcast. 
Via InvestorPlace
Why Is Biora Therapeutics (BIOR) Stock Up 12% Today?
Biora Therapeutics (BIOR) stock is on the rise Wednesday following news of feedback from the U.S. Food and Drug Administration (FDA). 
Via InvestorPlace
Bionano Genomics (BNGO) Stock Pops on Promising Publication
BNGO stock is on the move as just-released research study results offer hope in the ongoing battle against cancer. 
Via InvestorPlace
The Top 7 Stocks to Watch in 2023
Some of the most interesting stocks to watch in 2023 are those over which the bulls and bears are fighting, 
Via InvestorPlace
This Innovative Growth Stock Could Double or More in 2023
Investors have high expectations for Bionano Genomics, but they might not pan out. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
7 Drug Stocks That Will Soar in 2023
These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.